GRND vs DBD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

GRND

64.1
AI Score
VS
GRND Wins

DBD

36.2
AI Score

Investment Advisor Scores

GRND

64score
Recommendation
STRONG BUY

DBD

36score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric GRND DBD Winner
Forward P/E 0 12.1655 Tie
PEG Ratio 0 0 Tie
Revenue Growth 32.5% 1.7% GRND
Earnings Growth 25.0% 34.2% DBD
Tradestie Score 64.1/100 36.2/100 GRND
Profit Margin 18.8% 2.9% GRND
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY AVOID NEW MONEY GRND

Relative Price Performance (Last 90 Days)

GRND 1M: -10.0% · 3M: -6.5% DBD 1M: +7.8% · 3M: -23.9%

Current Technical Phase

GRND

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.1%), weak momentum, RSI 40

RSI (14): 39.6 · Price: $13.89

DBD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.2 · Price: $67.94

Fundamentals Snapshot

Metric GRND DBD
Market Cap — —
Forward P/E 17.8 9.7
Trailing P/E 29.9 22.4
Revenue (TTM) — —
Revenue Growth 0.3% 0.0%
Gross Margin 0.7% 0.3%
Operating Margin 0.2% 0.1%
EPS 0.47 3.03
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GRND is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.